Chloroprocaine 3% Gel Eye Drop as Topical Anestheticsin Phacoemulsification.
Status:
Completed
Trial end date:
2021-03-09
Target enrollment:
Participant gender:
Summary
Randomized clinical trial, multicenter, two-armed, to investigate and compare the clinical
efficacy of chloroprocaine 3% gel and tetracaine 0.5% eye drop as topical anestheticsin
phacoemulsification. This prospective, observer masked, randomised, controlled, equivalence
phase 3 study will be conducted in approximately 4 European Countries. Sintetica intends to
perform a phase 3 study on patients undergoing cataract surgery to assess the safety and
efficacy of topical anaesthesia using chloroprocaine gel.